Table 3.
Effect of OSCs in PNI animal models.
OSC origin | Surface marker expression in vitro | Models of PNI | Delivery system | Contribution to PNI regeneration | Reference |
---|---|---|---|---|---|
hOE-MSCs | CD13, CD44, CD90, CD166, CD146, CD73, CD29, CD105 | 2 mm facial nerve gap in rats | Nerve stumps | Promoted the movement score and electrophysiological results | [114] |
OE-MSCs | Nestin | 20 mm inferior laryngeal nerve gap in rats | Cells are injected into nerve graft | Enhanced laryngeal mobility and function score | [115] |
OE-MSCs | CD73, CD90, CD105, nestin, vimentin | Sciatic nerve crush in rats | Alginate/chitosan hydrogel | Improved motor and sensory nerve regeneration | [88] |
OSCs | β-tubulin, nestin, and GFAP | 10 mm sciatic nerve gap in rats | Biphasic conduit | Contributed functional, electrophysiological, and histological recovery | [116] |
OSCs | β-tubulin, GFAP, nestin, OMP, Musashi-1, sox-2, Nanog | Facial nerve crush model in mice | Biodegradable hydrogel | Accelerated the recovery from facial palsy and enhanced nerve regeneration | [87] |